Company Filing History:
Years Active: 2006-2013
Title: Maria Kesseler: Innovator in Enzymatic Proteins
Introduction
Maria Kesseler is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of enzymatic proteins, holding 2 patents that showcase her innovative work. Her inventions focus on the production of optically active alkanols and D-pantolactone, which have important applications in various industries.
Latest Patents
Kesseler's latest patents include "Dehydrogenases, the derivatives thereof, and method for the production of optically active alkanols." This invention relates to proteins that possess enzymatic activity for reducing substituted alkanones, such as 3-methylamino-1-(2-thienyl)-propan-1-one. Additionally, it encompasses nucleic acids coding for these proteins, nucleic acid constructs, vectors, genetically modified microorganisms, and methods for preparing optically active substituted alkanols, including (S)-3-methylamino-1-(2-thienyl)-(S)-propanol. Another notable patent is "L-pantolactone-hydrolase and a method for producing D-pantolactone." This invention focuses on proteins that hydrolyze L-pantolactone and includes nucleic acids coding for these proteins, nucleic acid constructs, vectors, genetically modified microorganisms, and a process for preparing D-pantolactone.
Career Highlights
Throughout her career, Kesseler has worked with notable companies, including BASF Aktiengesellschaft and BASF SE Corporation. Her experience in these organizations has allowed her to develop her expertise in enzymatic proteins and contribute to groundbreaking innovations in the field.
Collaborations
Kesseler has collaborated with esteemed colleagues, including Thomas Friedrich and Bernhard Hauer. These partnerships have further enriched her research and development efforts, leading to significant advancements in her area of expertise.
Conclusion
Maria Kesseler is a remarkable inventor whose work in enzymatic proteins has led to valuable patents and collaborations. Her contributions continue to impact the scientific community and industry, showcasing the importance of innovation in biotechnology.